The DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index.
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
Open accessAbstract
Acute myocardial infarction (MI) is a major cause of death and disability worldwide. In patients with MI, the treatment of choice for reducing acute myocardial ischemic injury and limiting MI size is timely and effective myocardial reperfusion using either thombolytic therapy or primary percutaneous coronary intervention (PPCI). However, the process of reperfusion can itself induce cardiomyocyte death, known as myocardial reperfusion injury, for which there is still no effective therapy. A number of new therapeutic strategies currently under investigation for preventing myocardial reperfusion injury have the potential to improve clinical outcomes in patients with acute MI treated with PPCI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In cases such as myocardial IR, nano drug delivery vehicles accumulate in the injured tissue due to inflammation-mediated increased vascular permeability.160”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [160]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Self-citationZhao, Z., Corvera, J. S., Halkos, M. E., Kerendi, F., Wang, N.-P., Guyton, R. A., & Vinten‐Johansen, J. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01064.2002 · Cited by 2,073
A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter
Stefani, D. D., Raffaello, A., Teardo, E., Szabó, I., & Rizzuto, R. (2011) · Nature · doi:10.1038/nature10230 · Cited by 1,957
Reimer, K. A., Lowe, J. E., Rasmussen, M. M., & Jennings, R. B. (1977) · Circulation · doi:10.1161/01.cir.56.5.786 · Cited by 1,944
Przyklenk, K., Bauer, B., Ovize, M., Kloner, R. A., & Whittaker, P. (1993) · Circulation · doi:10.1161/01.cir.87.3.893 · Cited by 1,379
Myocardial reperfusion: a double-edged sword?
D, E. B. M., & Kloner, R. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112160 · Cited by 1,368
Wu, K. C., Zerhouni, E. A., Judd, R. M., Lugo-Olivieri, C. H., Barouch, L. A., Schulman, S. P., Blumenthal, R. S., & Lima, J. A. C. (1998) · Circulation · doi:10.1161/01.cir.97.8.765 · Cited by 1,356
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
Piot, C. A., Croisille, P., Staat, P., Thibault, H., Rioufol, G., Mewton, N., Belghiti, R. E., Cung, T. T., Bonnefoy‐Cudraz, E., Angoulvant, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071142 · Cited by 1,339
Direct measurement of free radical generation following reperfusion of ischemic myocardium.
Zweier, J. L., Flaherty, J. T., & Weisfeldt, M. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1404 · Cited by 1,189
Ito, H., Tomooka, T., Sakai, N., Yu, H., Higashino, Y., Fujii, K., Masuyama, T., Kitabatake, A., & Minamino, T. (1992) · Circulation · doi:10.1161/01.cir.85.5.1699 · Cited by 1,052
Flagged first, then by citations
1 of the 115 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Miyamae, 1996, Am J Physiol., 271, H2145
- Lemasters, 1996, EXS., 76, 99
- Atar, 2009, EFX., 53, 720
- Ytrehus, 1994, Am J Physiol., 267, H2383
- Duncker, 1996, Am J Physiol., 270, H1189
Cited by
Sorted by citations
Items 501–600 of 1,001
Punicalagin Pretreatment Attenuates Myocardial Ischemia-Reperfusion Injury via Activation of AMPK
Ding, M., Wang, Y., Sun, D., Liu, Z., Wang, J., Li, X., Huo, C., Jia, X. T., Chen, W., Fu, F., et al. (2017) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x17500057 · Cited by 43
Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress
Ingoglia, G., Sag, C. M., Rex, N., Franceschi, L. D., Vinchi, F., Cimino, J., Petrillo, S., Wagner, S., Kreitmeier, K., Silengo, L., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.003 · Cited by 43
Barbaloin pretreatment attenuates myocardial ischemia-reperfusion injury via activation of AMPK
Zhang, P., Liu, X., Huang, G., Bai, C., Zhang, Z., & Li, H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.188 · Cited by 43
Benjanuwattra, J., Apaijai, N., Chunchai, T., Kerdphoo, S., Jaiwongkam, T., Arunsak, B., Wongsuchai, S., Chattipakorn, N., & Chattipakorn, S. C. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165893 · Cited by 44
Targeting Inflammation After Myocardial Infarction
Mahtta, D., Sudhakar, D., Koneru, S., Silva, G. V., Alam, M., Virani, S. S., & Jneid, H. M. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01358-2 · Cited by 43
Diao, L., & Zhang, Q. (2021) · Aging · doi:10.18632/aging.202520 · Cited by 43
Robertson-Gray, O., Walsh, S. K., Ryberg, E., Jönsson‐Rylander, A., Lipina, C., & Wainwright, C. L. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.487 · Cited by 42
Protective effects of catalpol on cardio-cerebrovascular diseases: A comprehensive review
Zhang, Z., Dai, Y., Xiao, Y., & Liu, Q. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.06.010 · Cited by 42
Karpov, O. A., Stotland, A. B., Raedschelders, K., Chazarin, B., Ai, L., Murray, C. I., & Eyk, J. E. V. (2024) · Physiological Reviews · doi:10.1152/physrev.00026.2023 · Cited by 43
Livkisa, D., Chang, T.-H., Burnouf, T., Czosseck, A., Le, N. T. N., Shamrin, G., Yeh, W.-T., Kamimura, M., & Lundy, D. J. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122502 · Cited by 42
Pang, L., Cai, Y., Tang, E. H. C., Yan, D., Kosuru, R., Li, H., Irwin, M. G., Ma, H., & Xia, Z. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3453059 · Cited by 42
Zeng, G., Liu, H., & Wang, H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.113 · Cited by 42
Zhang, Z., Tian, H., Yang, C., Liu, J., Zhang, H., Wang, J., Hu, S., Sun, Z., He, K., & Chen, G. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014397 · Cited by 42
Tsujioka, T., Sasaki, D., Takeda, A., Harashima, H., & Yamada, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010112 · Cited by 42
New Developments in Exosomal lncRNAs in Cardiovascular Diseases
Yuan, Z., & Huang, W. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.709169 · Cited by 42
Liao, Y., Ke, B., Long, X., Xu, J., & Wu, Y. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03603-2 · Cited by 41
Islam, R. M., & Hong, Z. (2024) · Mechanobiology in Medicine · doi:10.1016/j.mbm.2024.100085 · Cited by 44
Wang, C., Li, Y., Qian, X.-Q., Zhao, H., Wang, D., Zuo, G.-X., & Kuan, W. (2022) · Figshare · doi:10.6084/m9.figshare.20525647 · Cited by 41
Wang, Y., Li, J., Song, Y., Zhang, M., Shan, D., Liu, Y., Fang, M., Lv, F., Xiao, R., & Zhang, Y. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx147 · Cited by 41
Yuan, L., Dai, X., Fu, H., Sui, D., Lu, L., Yang, L., Zha, P., Wang, X., & Gong, G. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.052 · Cited by 41
Yang, S., Li, H., & Chen, L. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27663 · Cited by 41
Testori, C., Beitzke, D., Mangold, A., Sterz, F. R., Loewe, C., Weiser, C., Scherz, T., Herkner, H., & Lang, I. M. (2018) · Heart · doi:10.1136/heartjnl-2018-313705 · Cited by 41
Activation mechanisms and multifaceted effects of mast cells in ischemia reperfusion injury
He, Z., Ma, C., Yu, T., Song, J., Leng, J., Gu, X., & Li, J. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.01.022 · Cited by 41
Ren, D., Quan, N., Fedorova, J., Zhang, J., He, Z., & Li, J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101556 · Cited by 41
Canonical and Non-Canonical Roles of Connexin43 in Cardioprotection
Rusiecka, O. M., Montgomery, J., Morel, S., Batista-Almeida, D., Campenhout, R. V., Vinken, M., Girão, H., & Kwak, B. R. (2020) · Biomolecules · doi:10.3390/biom10091225 · Cited by 41
The forkhead box O3 (FOXO3): a key player in the regulation of ischemia and reperfusion injury
Omorou, M., Huang, Y., Gao, M., Mu, C., Xu, W., Han, Y., & Xu, H. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04755-2 · Cited by 40
Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction
Kindberg, K. M., Broch, K., Andersen, G. Ø., Anstensrud, A. K., Åkra, S., Woxholt, S., Tøllefsen, I. M., Ueland, T., Amundsen, B. H., Kløw, N., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101193 · Cited by 41
Targeting Mitochondria for Cardioprotection: Examining the Benefit for Patients
Dongworth, R. K., Hall, A. R., Burke, N., & Hausenloy, D. J. (2014) · Future Cardiology · doi:10.2217/fca.14.6 · Cited by 40
Self-citationMG53: Biological Function and Potential as a Therapeutic Target
Zhang, Y., Wu, H., Lv, F., & Xiao, R. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.108241 · Cited by 40
Borosch, S., Dahmen, E., Beckers, C., Stoppe, C., Buhl, E. M., Denecke, B., Goetzenich, A., & Kraemer, S. (2017) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2017.1390391 · Cited by 43
Protective effect of morin on myocardial ischemia‑reperfusion injury in rats
Liu, S., Wu, N., Miao, J., Huang, Z., Li, X., Jia, P., Guo, Y., & Jia, D. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3743 · Cited by 40
Thomas, D., Christ, T., Fabritz, L., Goette, A., Hammwöhner, M., Heijman, J., Kockskämper, J., Linz, D., Odening, K. E., Schweizer, P. A., et al. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1377-1 · Cited by 40
Wu, H., Wu, J., & Ni, Z.-L. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1580494 · Cited by 40
RetractedGuo, R., Gan, L., Lau, W. B., Yan, Z., Xie, D., Gao, E., Christopher, T. A., Lopez, B. L., Ma, X., & Wang, Y. (2019) · Circulation Journal · doi:10.1253/circj.cj-18-1391 · Cited by 40
Luo, M., Sun, Q., Zhao, H., Tao, J., & Yan, D. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28791 · Cited by 40
Cerium- and Iron-Oxide-Based Nanozymes in Tissue Engineering and Regenerative Medicine
Jansman, M. M. T., & Hosta‐Rigau, L. (2019) · Catalysts · doi:10.3390/catal9080691 · Cited by 41
Jiang, T., Zhang, L., Ding, M., & Li, M. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s220396 · Cited by 40
Yuan, X., Juan, Z., Zhang, R., Sun, X., Yan, R., Yue, F., Huang, Y., Yu, J., & Xia, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00028 · Cited by 40
Billah, M., Ridiandries, A., Allahwala, U. K., Mudaliar, H., Dona, A. C., Hunyor, S. N., Khachigian, L. M., & Bhindi, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051692 · Cited by 41
Viswanadha, V. P., Dhivya, V., Beeraka, N. M., Huang, C., Владимировна, Г. Л., Minyaeva, N. N., Chubarev, V. N., Михалева, Л. М., Tarasov, V. V., & Aliev, G. M. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173524 · Cited by 40
Histone Methylation and Oxidative Stress in Cardiovascular Diseases
Yi, X., Zhu, Q., Wu, X., Tan, T.-T., & Jiang, X.-J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6023710 · Cited by 42
Liao, J., Cui, H., Huang, W., Shao, X., Song, Y., Liu, L., Ai, N., & Fan, X. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.08.029 · Cited by 40
Tow, W., Chee, P. Y., Sundralingam, U., & Palanisamy, U. D. (2022) · Nutrients · doi:10.3390/nu14173494 · Cited by 42
Hu, B., Tian, T., Li, X., Hao, P.-P., Liu, W.-C., Chen, Y.-G., Jiang, T., Chen, P.-S., Cheng, Y., & Xue, F. (2023) · Redox Report · doi:10.1080/13510002.2022.2158526 · Cited by 39
Chen, X., Lv, Y., Zhao, D., Zhang, L. J., Zheng, F., Yang, J., Li, X., Wang, L., Guo, L., Pan, Y., et al. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2622-9 · Cited by 39
Xuan, F., Jian, J., Lin, X., Huang, J., Jiao, Y., Huang, W., Li, J., Shi, Z., & Huang, R. (2016) · Cardiovascular Toxicology · doi:10.1007/s12012-016-9358-y · Cited by 39
Role of glycogen synthase kinase following myocardial infarction and ischemia–reperfusion
Ghaderi, S., Alidadiani, N., Dilaver, N., Heidari, H. R., Parvizi, R., Rahbarghazi, R., Soleimanirad, J., & Baradaran, B. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1376-0 · Cited by 39
Cao, L., Chen, Y., Zhang, Z., Li, Y., & Zhao, P. (2018) · Shock · doi:10.1097/shk.0000000000001175 · Cited by 39
PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation
Xie, B., Liu, X., Yang, J., Cheng, J., Gu, J., & Xue, S. (2018) · BMC Cell Biology · doi:10.1186/s12860-018-0176-x · Cited by 39
Li, Y., Sun, J., Hu, L., Ma, X., Zhou, G., & Huang, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28897 · Cited by 39
Luo, Y., Wan, Q., Xu, M., Zhou, Q., Chen, X., Yin, D., He, H., & He, M. L. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.06.036 · Cited by 39
Zou, L., Ma, X., Lin, S., Wu, B., Yang, C., & Peng, C. (2019) · Bioscience Reports · doi:10.1042/bsr20190210 · Cited by 39
RetractedZhang, M., Wang, X., Shi, J., & Yu, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.749113 · Cited by 39
Lin, J., Li, Q., Jin, T., Wang, J., Gong, Y., Lv, Q., Wang, M., Chen, J. C., Shang, M., Zhao, Y., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04533-1 · Cited by 39
Saeedi‐Boroujeni, A., Purrahman, D., Shojaeian, A., Poniatowski, Ł. A., Rafiee, F., & Mahmoudian‐Sani, M. (2023) · Journal of Inflammation · doi:10.1186/s12950-023-00327-0 · Cited by 39
The role of the adenosine system in epilepsy and its comorbidities
Baltos, J., Casillas-Espinosa, P. M., Rollo, B., Gregory, K. J., White, P. J., Christopoulos, A., Kwan, P., O'Brien, T. J., & May, L. T. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16094 · Cited by 39
Modulation of IL-33/ST2 signaling as a potential new therapeutic target for cardiovascular diseases
Thanikachalam, P. V., Ramamurthy, S., Mallapu, P., Varma, S. R., Jayaraj, K. N., Abourehab, M. A. S., & Kesharwani, P. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.06.003 · Cited by 38
Huang, H., Lai, S., Wan, Q., Qi, W., & Liu, J. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0457 · Cited by 38
Mao, Z.-J., Lin, H. M., Hou, J., Zhou, Q., Wang, Q., & Chen, Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5793867 · Cited by 39
Lu, Q., Jian, Q., Duan, Y., Sun, Y., Yu, S., Li, B., & Zhang, G. M. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000710 · Cited by 38
Bayat, F., Hosseinpour-Moghadam, R., Mehryab, F., Fatahi, Y., Shakeri, N., Dinarvand, R., ten Hagen, T. L. M., & Haeri, A. (2020) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2020.102121 · Cited by 38
Caloric restriction mimetics for the treatment of cardiovascular diseases
Sciarretta, S., Forte, M., Castoldi, F., Frati, G., Versaci, F., Sadoshima, J., Kroemer, G., & Maiuri, M. C. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa297 · Cited by 39
Ning, S., Li, Z., Ji, Z., Fan, D., Wang, K., Wang, Q., Hua, L., Zhang, J., Meng, X., & Yuan, Y. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11636 · Cited by 38
Han, Y., Dong, B., Chen, M., & Yao, C. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03998-y · Cited by 38
Cellular crosstalk in cardioprotection: Where and when do reactive oxygen species play a role?
Martins‐Marques, T., Rodríguez‐Sinovas, A., & Girão, H. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.044 · Cited by 38
Erikson, J. M., Valente, A. J., Mummidi, S., Kandikattu, H. K., DeMarco, V. G., Bender, S. B., Fay, W. P., Siebenlist, U. K., & Chandrasekar, B. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.764522 · Cited by 38
Considerations for the Bioengineering of Advanced Cardiac In Vitro Models of Myocardial Infarction
Sharma, P., Wang, X., Ming, C. L. C., Vettori, L., Figtree, G. A., Boyle, A., & Gentile, C. (2021) · Small · doi:10.1002/smll.202003765 · Cited by 40
Lu, Y., Chen, K., Zhao, W., Hua, Y., Bao, S., Zhang, J., Wu, T., Ge, G., Yu, Y., Sun, J., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02189-3 · Cited by 37
Alves, L. D. F., Moore, J. B., & Kell, D. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169082 · Cited by 39
Liu, H., Song, Y., Wang, H., Zhou, Y., Xu, M., & Xian, J. (2025) · Phytotherapy Research · doi:10.1002/ptr.8433 · Cited by 37
Therapeutic targeting of autophagy in myocardial infarction and heart failure
Riquelme, J. A., Chávez, M. N., Mondaca‐Ruff, D., Bustamante, M., Vicencio, J. M., Quest, A. F. G., & Lavandero, S. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2016.1202760 · Cited by 37
Inhibition of Oxidative Stress in Renal Ischemia-Reperfusion Injury
Choi, E. K., Jung, H., Kwak, K. H., Yi, S., Lim, J. A., Park, S. H., Park, J., Kim, S., Jee, D., & Lim, D. G. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001565 · Cited by 37
Efentakis, P., Rizakou, A., Christodoulou, E., Chatzianastasiou, A., López, M. G., Leon, R. M., Balafas, E., Kadoglou, N. P. E., Tseti, I. K., Skaltsa, H. D., et al. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.08.005 · Cited by 37
Cardiac Ischemia/Reperfusion Injury: The Beneficial Effects of Exercise
Borges, J. P., & Verdoorn, K. D. S. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4307-9_10 · Cited by 38
Myocardial Infarction: An Overview of STEMI and NSTEMI Physiopathology and Treatment
Kingma, J. G. (2018) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2018.811049 · Cited by 39
A biocompatible redox MRI probe based on a Mn( ii )/Mn( iii ) porphyrin
Pinto, S. M. A., Calvete, M. J. F., Ghica, M. E., Soler, S., Gallardo, I., Pallier, A., Laranjo, M., Cardoso, A. M., Castro, M. M. C. A., Brett, C. M. A., et al. (2019) · Dalton Transactions · doi:10.1039/c8dt04775h · Cited by 37
Zhao, Y., Zhao, J., Zhang, L., Shan, R.-G., Sun, Z.-Z., Wang, K., Chen, J.-Q., & Mu, J.-X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108697 · Cited by 37
RetractedTraditional Chinese Medicine for Coronary Heart Disease: Clinical Evidence and Possible Mechanisms
Zhang, K., Zheng, Q., Zhu, P.-C., Tong, Q., Zhuang, Z., Zhu, J., Bao, X., Huang, Y.-Y., Zheng, G., & Wang, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00844 · Cited by 37
Bielska, A., Niemira, M., & Kretowski, A. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063153 · Cited by 37
Halade, G. V., Kain, V., Hossain, S., Parcha, V., Limdi, N. A., & Arora, P. K. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00115.2022 · Cited by 38
Lin, J., Lai, X., Fan, X., Ye, B., Zhong, L., Zhang, Y., Shao, R., Shi, S., Huang, W., Su, L., et al. (2022) · Genes · doi:10.3390/genes13112133 · Cited by 37
Bai, M., Zhang, J., Chen, D., Lu, M., Li, J., Zhang, Z., & Niu, X. (2023) · European journal of medical research · doi:10.1186/s40001-022-00967-7 · Cited by 37
Seeger, J. P. H., Timmers, S., Ploegmakers, D. J. M., Cable, N. T., Hopman, M. T. E., & Thijssen, D. H. J. (2016) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2016.03.010 · Cited by 37
Toldo, S. A., Quader, M. A., Salloum, F. N., Mezzaroma, E., & Abbate, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060958 · Cited by 38
Chen, G., Yang, L., Zhong, L., Kutty, S., Wang, Y., Cui, K., Xiu, J., Cao, S., Huang, Q., Liao, W., et al. (2016) · Scientific Reports · doi:10.1038/srep30643 · Cited by 37
Cheng, Y.-F., Chang, Y.-T., Chen, W.-H., Shih, H.-C., Chen, Y., Shyu, B., & Chen, C. (2017) · Nature Communications · doi:10.1038/s41467-017-00891-z · Cited by 37
Hou, Z., Zhou, Y., Yang, H., Liu, Y., Mao, X., Qin, X., Li, X., Zhang, X., & Hu, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.077 · Cited by 37
Wang, Y.-H., Li, S.-A., Huang, C.-H., Su, H.-H., Chen, Y., Chang, J. T., & Huang, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00636 · Cited by 37
Mendoza‐Torres, E., Riquelme, J. A., Vielma, A. Z., Ramírez‐Sagredo, A., Gabrielli, L., Bravo, R., Jalil, J., Rothermel, B. A., Sánchez, G., Ocaranza, M. P., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.07.022 · Cited by 37
Pang, L., Cai, Y., Tang, E. H. C., Irwin, M. G., Ma, H., & Xia, Z. (2016) · Journal of Diabetes Research · doi:10.1155/2016/1324347 · Cited by 36
Li, S., Liu, C., Gu, L., Wang, L., Shang, Y., Liu, Q., Wan, J., Shi, J. Y., Wang, F., Xu, Z., et al. (2016) · Open Biology · doi:10.1098/rsob.160177 · Cited by 36
Dong, W., Zhou, M., Dong, M., Pan, B., Liu, Y., Shao, J., Gu, X., Huang, Y., Li, G., Wang, Y., et al. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.11.002 · Cited by 36
Qin, C., Zhang, H., Gu, J., Xu, F., Liang, H.-M., Fan, K.-J., Shen, J., Xiao, Z., Zhang, E., & Hu, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7515 · Cited by 36
He, Y., Li, C., Ma, Q., & Chen, S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.195 · Cited by 36
Liu, Y., Paterson, M. R., Baumgardt, S. L., Irwin, M. G., Xia, Z., Bosnjak, Z. J., & Ge, Z. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy157 · Cited by 36
Developing LRP1 Agonists into a Therapeutic Strategy in Acute Myocardial Infarction
Potere, N., Buono, M. G. D., Niccoli, G., Crea, F., Toldo, S. A., & Abbate, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030544 · Cited by 36
Cardiac Muscle Membrane Stabilization in Myocardial Reperfusion Injury
Houang, E. M., Bartos, J. A., Hackel, B. J., Lodge, T. P., Yannopoulos, D., Bates, F. S., & Metzger, J. M. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.01.009 · Cited by 36
Li, Y., Liang, P., Jiang, B., Tang, Y., Lv, Q., Hao, H., Liu, Z., & Xiao, X. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.06.017 · Cited by 36
Long, Y., Wu, J., Xie, P., Yu, J. Z., Li, X., Wang, J., & Zheng, H. (2019) · PeerJ · doi:10.7717/peerj.7165 · Cited by 36
Essential Role of Nonessential Amino Acid Glutamine in Atherosclerotic Cardiovascular Disease
Chen, J., Zhang, S., Wu, J., Wu, S., Xu, G., & Wei, D. (2019) · DNA and Cell Biology · doi:10.1089/dna.2019.5034 · Cited by 37
Metadata
- Authors
- Hausenloy, D. J., & Yellon, D. M.
- Affiliations
- University College London (GB)
- Corresponding author
- Yellon, Derek M.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-01-02
- Volume
- 123
- Issue
- 1
- Pages
- 92-100
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3533275
- OpenAlex
- W2051395985
- Cited by
- 2,357
- References
- 115
- Citations by year
- 2026: 176 · 2025: 177 · 2024: 226 · 2023: 218 · 2022: 236 · 2021: 231 · 2020: 240 · 2019: 226 · 2018: 172 · 2017: 124 · 2016: 130 · 2015: 101 · 2014: 69 · 2013: 28
- FWCI
- 16.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0510-10164)
- British Heart Foundation (RG/03/007, RG/08/015/26411, FS/06/023)
- University College London
- Medical Research Council (MR/K002066/1)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- myocardial ischemia-reperfusion injury, acute myocardial infarction, cardiomyocyte death, primary percutaneous coronary intervention, thrombolysis, therapeutic target, cardioprotection
- MeSH terms
- Animals, Humans, Myocardial Infarction, Myocardial Reperfusion Injury, Thrombolytic Therapy, Cell Death, Myocytes, Cardiac, Percutaneous Coronary Intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
